The impact of coronavirus disease 2019 on genitourinary and prostate cancer care and clinical trials: A qualitative exploration of the Australian and New Zealand experience

Author:

Roberts Natasha A.123,Dhillon Haryana M.43,Paterson Catherine56783,Schubach Kathryn9103,McJannett Margaret3,

Affiliation:

1. Centre for Clinical Research University of Queensland Brisbane Australia

2. Cancer Care Services Metro North Health Service Herston Australia

3. Australian New Zealand Urogenital and Prostate Cancer Trials Group Sydney Australia

4. Centre for Medical Psychology and Evidence‐Based Decision‐Making School of Psychology, Faculty of Science University of Sydney Sydney Australia

5. School of Nursing, Midwifery and Public Health University of Canberra Canberra Australia

6. Prehabilitation, Activity Cancer Exercise and Survivorship (PACES) Research Group University of Canberra Canberra Australia

7. Canberra Health Services and ACT Health SYNERGY Nursing and Midwifery Research Centre ACT Health Directorate Level 3 Canberra Hospital Canberra Australia

8. Robert Gordon University Aberdeen UK

9. Men's Health Melbourne Melbourne Australia

10. Australian and New Zealand Urology Nurses Society (ANZUNS) Marrickville Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Reference38 articles.

1. World Health Organization.Coronavirus disease (COVID‐19) pandemic. Accessed February 2021https://www.who.int/emergencies/diseases/novel‐coronavirus‐2019

2. National COVID‐19 Clinical Evidence Taskforce.Caring for people with COVID‐19. Supporting Australia's healthcare professionals with continually updated evidence‐based clinical guidelines. Accessed February 2021https://covid19evidence.net.au/

3. The Role of Telehealth During the COVID-19 Pandemic Across the Interdisciplinary Cancer Team: Implications for Practice

4. Australian Government Department of Health.Coronavirus disease (COVID‐19) epidemiology reports. COVID‐19 Epidemiology Report 13.2020.https://doi.org/10.33321/cdi.2020.44.35

5. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3